- improved glucose tolerance / IMPC
- decreased circulating fructosamine level / IMPC
- decreased monocyte cell number / IMPC
- decreased KLRG1-positive NK cell number / IMPC
- increased circulating creatinine level / IMPC
- abnormal vibrissa morphology / IMPC
- increased bone mineral content / IMPC
- increased circulating amylase level / IMPC
STOCK Tg(H2-K1-Ifnb1)10Seif Ifnar1tm1Agt/Orl
Status | Available to order |
EMMA ID | EM:07149 |
Citation information | RRID:IMSR_EM:07149 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | STOCK Tg(H2-K1-Ifnb1)10Seif Ifnar1tm1Agt/Orl |
Alternative name | Ifnar1tm1Agt/Ifnar1tm1Agt Tg(H2-K1-Ifnb1)10Seif/Tg(H2- K1-Ifnb1)10Seif |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Ifnar1tm1Agt, Tg(H2-K1-Ifnb1)10Seif |
Gene/Transgene symbol | Ifnar1, Tg(H2-K1-Ifnb1)10Seif |
Information from provider
Provider | Isabelle Seif |
Provider affiliation | Neuropharmacologie, Faculte de pharmacie (Universite Paris-Sud) |
Genetic information | Random integration of a transgene for IFN beta expressed under the control of a H2-K1 promoter resulted in insertion of the transgene into exon 2 of Prps1l3 and a partial duplication of Prps1l3 and Slc25a21, on chromosome 12. |
Phenotypic information | Excess type I interferon signaling in the seminiferous tubules of Tg10 mice leads to germ cell loss and sterility. Testicular integrity and normal fertility is maintained in Tg10 mice invalidated for the type I IFN receptor (Tg10-Ifnar1-/-). |
Breeding history | Inbred for 5 generations. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | yes |
Immunocompromised | yes |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | homozygous C3H/He males, homozygous C3H/He females |
Breeding at archiving centre | Males: transgenic for Tg(H2-K1-Ifnb1)10Seif and homozygous knock-out for Ifnar1-tm1Agt. Females: transgenic and homozygous knock-out. |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (allele matching)
- decreased bone mineral density / MGI
- increased tumor growth/size / MGI
- abnormal osteoclast morphology / MGI
- abnormal response to infection / MGI
- impaired natural killer cell mediated cytotoxicity / MGI
- decreased tumor necrosis factor secretion / MGI
- decreased interferon-alpha secretion / MGI
- decreased interferon-beta secretion / MGI
- decreased interleukin-6 secretion / MGI
- increased susceptibility to bacterial infection induced morbidity/mortality / MGI
- abnormal inflammatory response / MGI
- abnormal dendritic cell physiology / MGI
- increased susceptibility to viral infection / MGI
- abnormal immunoglobulin level / MGI
- abnormal cytokine secretion / MGI
- corneal vascularization / MGI
- increased susceptibility to viral infection induced morbidity/mortality / MGI
- abnormal NK cell physiology / MGI
- altered susceptibility to infection / MGI
- immune system phenotype / MGI
- abnormal CD8-positive, alpha-beta T cell physiology / MGI
- abnormal interferon-gamma secretion / MGI
- increased circulating interleukin-12 level / MGI
- abnormal testis morphology / MGI
- seminiferous tubule degeneration / MGI
- reduced male fertility / MGI
- male infertility / MGI
- abnormal spermiogenesis / MGI
- decreased litter size / MGI
- abnormal seminiferous tubule morphology / MGI
- oligozoospermia / MGI
- abnormal male reproductive system physiology / MGI
- decreased testis weight / MGI
- reproductive system phenotype / MGI
- abnormal male germ cell apoptosis / MGI
- early reproductive senescence / MGI
MGI phenotypes (gene matching)
- decreased bone mineral density / MGI
- increased leukocyte cell number / MGI
- altered susceptibility to infection / MGI
- abnormal inflammatory response / MGI
- increased incidence of induced tumors / MGI
- abnormal dendritic cell physiology / MGI
- increased susceptibility to viral infection / MGI
- abnormal macrophage physiology / MGI
- abnormal immunoglobulin level / MGI
- abnormal cytokine secretion / MGI
- no phenotypic analysis / MGI
- increased tumor growth/size / MGI
- abnormal CD8-positive, alpha-beta T cell physiology / MGI
- increased incidence of tumors by chemical induction / MGI
- abnormal osteoclast morphology / MGI
- abnormal response to infection / MGI
- impaired natural killer cell mediated cytotoxicity / MGI
- immune system phenotype / MGI
- corneal vascularization / MGI
- abnormal enzyme/coenzyme activity / MGI
- decreased NK cell number / MGI
- abnormal interferon-gamma secretion / MGI
- decreased tumor necrosis factor secretion / MGI
- decreased interferon-alpha secretion / MGI
- decreased interferon-beta secretion / MGI
- increased circulating interleukin-12 level / MGI
- decreased interleukin-6 secretion / MGI
- increased susceptibility to bacterial infection induced morbidity/mortality / MGI
- increased susceptibility to viral infection induced morbidity/mortality / MGI
- abnormal NK cell physiology / MGI
- abnormal testis morphology / MGI
- seminiferous tubule degeneration / MGI
- reduced male fertility / MGI
- male infertility / MGI
- abnormal spermiogenesis / MGI
- decreased litter size / MGI
- abnormal seminiferous tubule morphology / MGI
- oligozoospermia / MGI
- abnormal male reproductive system physiology / MGI
- decreased testis weight / MGI
- reproductive system phenotype / MGI
- abnormal male germ cell apoptosis / MGI
- early reproductive senescence / MGI
Literature references
- Excess type I interferon signaling in the mouse seminiferous tubules leads to germ cell loss and sterility.;Satie Anne-Pascale, Mazaud-Guittot Severine, Seif Isabelle, Mahé Dominique, He Zhiguo, Jouve Guilhem, Jégou Bernard, Dejucq-Rainsford Nathalie, ;2011;The Journal of biological chemistry;286;23280-95; 21515676
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).